What if … we could put bad sleeping habits to bed? 01 September 2022This month, we are aiming to debunk some of the misconceptions that are keeping us up at night as part of our commitment to helping members get a better night’s sleep. Follow us on our socials for our “Sleepy September” A to Zzzz of sleep myths.Read More
It's time to pursue benefits of new and emerging therapies.23 August 2022At HIF our goal is to ensure our members have choice and access to the best cover to suit their lifestyle and we recognise that sometimes, in order to do that, we need to think outside the square.Read More
What if patients could improve their mental health outcomes with emerging therapies?27 July 2022The role of alternative emerging therapies such as psilocybin and MDMA in treating mental health conditions was the subject of a timely and thought-provoking discussion at the Australian Medical Association (WA) conference MEDCON22 in Perth last week.Read More
Claiming MDMA on health insurance? It could become a reality.26 July 2022Ahead of HIF’s Mental Health and Emerging Therapies session at MEDCON22, Mr James was invited onto the West Live podcast, where he talked to the show’s host Ben O’Shea about research into psychedelics and what it could mean to the private health insurance industry.Read More
Could psychedelic drugs be the answer to treating mental health?23 July 2022Our CEO Justin James sat down with 6PR’s Oliver Peterson to address the possibility of using drugs like MDMA in therapy to treat chronic mental health conditions.Read More